TY - JOUR
T1 - Invasive hepatic mucormycosis
T2 - A case report and review of the literature
AU - Karigane, Daiki
AU - Kikuchi, Taku
AU - Sakurai, Masatoshi
AU - Kato, Jun
AU - Yamane, Yusuke
AU - Hashida, Risa
AU - Abe, Ryohei
AU - Hatano, Mami
AU - Hasegawa, Naoki
AU - Wakayama, Megumi
AU - Shibuya, Kazutoshi
AU - Okamoto, Shinichiro
AU - Mori, Takehiko
N1 - Publisher Copyright:
© 2018 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases
Copyright:
Copyright 2019 Elsevier B.V., All rights reserved.
PY - 2019/1
Y1 - 2019/1
N2 - Mucormycosis generally develops under immunocompromised conditions, including hematological malignancies and solid organ or hematopoietic stem cell transplantation. Although mucormycosis usually affects the lungs and paranasal sinuses, sporadic cases of invasive mucormycosis of the liver have been reported. We hereby report a patient with myelofibrosis who developed hepatic mucormycosis diagnosed by post-mortem examination. An extensive literature review identified 13 reported cases of hepatic mucormycosis, including ours, without lung involvement. Most of the underlying diseases or conditions were hematological malignancies and solid organ transplantation. Three cases had splenic lesions and four had gastrointestinal lesions, suggesting the possibility of translocation to the liver and/or spleen from the gastrointestinal tracts. Hepatic mucormycosis should be recognized as one of the presentations of invasive mucormycosis, especially when hepatic nodules are found in immunocompromised patients such as those with hematological malignancy or recipients of solid organ transplantation.
AB - Mucormycosis generally develops under immunocompromised conditions, including hematological malignancies and solid organ or hematopoietic stem cell transplantation. Although mucormycosis usually affects the lungs and paranasal sinuses, sporadic cases of invasive mucormycosis of the liver have been reported. We hereby report a patient with myelofibrosis who developed hepatic mucormycosis diagnosed by post-mortem examination. An extensive literature review identified 13 reported cases of hepatic mucormycosis, including ours, without lung involvement. Most of the underlying diseases or conditions were hematological malignancies and solid organ transplantation. Three cases had splenic lesions and four had gastrointestinal lesions, suggesting the possibility of translocation to the liver and/or spleen from the gastrointestinal tracts. Hepatic mucormycosis should be recognized as one of the presentations of invasive mucormycosis, especially when hepatic nodules are found in immunocompromised patients such as those with hematological malignancy or recipients of solid organ transplantation.
KW - Hepatic mucormycosis
KW - Liver
KW - Myelofibrosis
KW - Solid organ transplantation
UR - http://www.scopus.com/inward/record.url?scp=85050399349&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85050399349&partnerID=8YFLogxK
U2 - 10.1016/j.jiac.2018.06.013
DO - 10.1016/j.jiac.2018.06.013
M3 - Article
C2 - 30057341
AN - SCOPUS:85050399349
SN - 1341-321X
VL - 25
SP - 50
EP - 53
JO - Journal of Infection and Chemotherapy
JF - Journal of Infection and Chemotherapy
IS - 1
ER -